A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

Summary

This clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in patients with Multiple System Atrophy.

Timeline

Start

2026-01-05

Primary completion

2027-10

Completion

2031-07

Drugs

Indications